Ignite Creation Date:
2025-12-24 @ 2:48 PM
Ignite Modification Date:
2026-02-23 @ 6:29 AM
Study NCT ID:
NCT02617459
Status:
COMPLETED
Last Update Posted:
2023-05-12
First Post:
2015-11-18
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Levobetaxolol Hydrochloride Eye Drops for Treatment of Primary Open-angle Glaucoma or Ocular Hypertension
Sponsor:
Zhaoke (Guangzhou) Ophthalmology Pharmaceutical Ltd.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2019-01-04
Start Date Type:
ACTUAL
Primary Completion Date:
2021-07-01
Primary Completion Date Type:
ACTUAL
Completion Date:
2021-07-01
Completion Date Type:
ACTUAL
First Submit Date:
2015-11-18
First Submit QC Date:
None
Study First Post Date:
2015-12-01
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-05-10
Last Update Post Date:
2023-05-12
Last Update Post Date Type:
ACTUAL